Apoptosis-related Fas and FasL gene polymorphisms' associations with knee osteoarthritis

Rheumatology International

Volumn 33, Issue 8, 2013, Pages 2039-2043

  Sezgin, Melek ^a   Barlas, Ibrahim Ömer ^a   Yildir, Seyfi ^b   Türköz, Gözde ^a   Ankarali, Handan Çamdeviren ^c   Şahin, Günşah ^a   Erdal, Mehmet Emin ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b MERSIN STATE HOSPITAL   (Turkey)

^c DUZCE UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Fas; Fas ligand; Gene polymorphism; Osteoarthritis

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GENOMIC DNA;

ADULT; ALLELE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

AGED; ALLELES; ANTIGENS, CD95; FAS LIGAND PROTEIN; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TURKEY;

EID: 84880918250     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2688-1     Document Type: Article

References (39)

1. Hamerman D (1993) Aging and osteoarthritis: basic mechanisms. J Am Geriatr Soc 41:760-770
2. Westacott CI, Sharif M (1996) Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 25:254-272
3. Goldring MB (2000) The role of the chondrocyte in osteoarthritis. Arthritis Rheum 43:1916-1926
4. Sharif M, Whitehouse A, Sharman P, Perry M, Adams M (2004) Increased apoptosis in human osteoarthritic cartilage corresponds to reduced cell density and expression of caspase-3. Arthritis Rheum 50:507-515
5. Aigner T, Kim HA (2002) Apoptosis and cellular vitality: issues in osteoarthritic cartilage degradation. Arthritis Rheum 46:1986-1996
6. Goggs R, Carter SD, Schulze-Tanzil G, Shakibaei M, Mobasheri A (2002) Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis. Vet J 166:140-158
7. Lotz M, Hashimoto S, Kuhn K (1999) Mechanisms of chondrocyte apoptosis. Osteoarthr Cartil 7:389-391
8. Mobasheri A (2002) Role of chondrocyte death and hypocellularity in aging human articular cartilage and the pathogenesis of osteoarthritis. Med Hypotheses 58:193-197
9. Blanco FJ, Guitian R, Vazquez-Martul E, de Toro FJ, Galdo F (1998) Osteoarthritis chondrocytes die by apoptosis: a possible pathway for osteoarthritis pathology. Arthritis Rheum 41:284-289
10. Heraud F, Heraud A, Harmand MF (2000) Apoptosis in normal and osteoarthritic human articular cartilage. Ann Rheum Dis 59:959-965
11. Kim HA, Suh DI, Song YW (2001) Relationship between chondrocyte apoptosis and matrix depletion in human articular cartilage. J Rheumatol 28:2038-2045
12. Pennock AT, Robertson CM, Emmerson BC, Harwood FL, Amiel D (2007) Role of apoptotic and matrix-degrading genes in articular cartilage and meniscus of mature and aged rabbits during development of osteoarthritis. Arthritis Rheum 56:1529-1536
13. Alenzi FQ (2005) Apoptosis and diseases: regulation and clinical relevance. Saudi Med J 26:1679-1690
14. D'Lima DD, Hashimoto S, Chen PC, Lotz MK, Colwell CW Jr (2001) Prevention of chondrocyte apoptosis. J Bone Joint Surg Am 83:25-26
15. Kim HA, Lee YJ, Seong SC, Choe KW, Song YW (2000) Apoptotic chondrocyte death in human osteoarthritis. J Rheumatol 27:455-462
16. Musumeci G, Loreto C, Carnazza ML, Martinez G (2011) Characterization of apoptosis in articular cartilage derived from the knee joints of patients with osteoarthritis. Knee Surg Sports Traumatol Arthrosc 192:307-313
17. Itoh N, Yonehara S, Ishii A et al (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243
18. Oehm A, Behrmann I, Falk W et al (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. sequence identity with the Fas antigen. J Biol Chem 267:10709-10715
19. Huang QR, Morris D, Manolios N (1997) Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol 34:577-582
20. Sibley K, Rollinson S, Allan JM et al (2003) Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res 63:4327-4330
21. Wu J, Metz C, Xu X, Abe R, Gibson AW, Edberg JC (2003) A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. J Immunol 70:132-138
22. Cohen PL, Eisenberg RA (1991) Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243-269
23. Das H, Koizumi T, Sugimoto T, Chakraborty S, Ichimura T, Hasegawa K, Nishimura R (2000) Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR. Br J Cancer 82:1682-1688
24. Mohammadzadeh A, Pourfathollah AA, Tahoori MT, Daneshmandi S, Langroudi L, Akhlaghi M (2011) Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients. Rheumatol Int 31. doi: 10.1007/s00296-011-2065-x
25. Wang LE, Cheng L, Spitz MR, Wei Q (2003) Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. Lung Cancer 42:1-8
26. Lai HC, Sytwu HK, Sun CA et al (2003) Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis. Int J Cancer 103:221-225
27. Zhu J, Qin C, Wang M et al (2010) Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma. Mol Carcinog 49:810-817
28. Li C, WuW Liu J et al (2006) Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis. Pharmacogenet Genomics 16:245-251
29. Sun T, Miao X, Zhang X, Tan W, Xiong P, Lin D (2004) Polymorphisms of death pathway genes FAS and FASL in esophageal squamous cell carcinoma. J Natl Cancer Inst 96:1030-1036
30. Chen JY, Wang CM, Ma CC, Chow YH, Luo SF (2005) The -844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE. Genes Immun 6:123-128
31. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
32. Fuks A, Parton LA, Polavarapu S, Netta D, Strassberg S, Godi I, Hsu CD (2005) Polymorphism of Fas and Fas ligand in preterm premature rupture of membranes in singleton pregnancies. Am J Obstet Gynecol 193:1132-1136
33. Aguilar-Reina J, Ruiz-Ferrer M, Pizarro MA, Antiñolo G (2005) The-670A>G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C. J Viral Hepat 12:568-573
34. Li C, Larson D, Zhang Z et al (2006) Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma. Pharmacogenet Genomics 16:253-263
35. Zhang X, Miao X, Sun T, Tan W, Qu S, Xiong P, Zhou Y, Lin D (2005) Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J Med Genet 42:479-484
36. Stuck BJ, Pani MA, Besrour F, Segni M, Krause M, Usadel KH, Badenhoop K (2003) Fas ligand gene polymorphisms are not associated with Hashimoto's thyroiditis and Graves' disease. Hum Immunol 64:285-289
37. Hashimoto S, Setareh M, Ochs RL, Lotz M (1997) Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum 40:1749-1755
38. Robertson CM, Pennock AT, Harwood FL, Pomerleau AC, Allen RT, Amiel D (2006) Characterization of pro-apoptotic and matrix-degradative gene expression following induction of osteoarthritis in mature and aged rabbits. Osteoarthritis Cartilage 14:471-476
39. Kanemitsu S, Ihara K, Saifddin A, Otsuka T, Takeuchi T, Nagayama J (2002) A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus. J Rheumatol 29:1183-1188